Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

Altigg Therapeutics Inc
Profile last edited on: 12/6/21      CAGE: 8H7A0      UEI: K557KMZL2UY5

Business Identifier: Human antibodies as therapeutics for infectious disease
Year Founded
2019
First Award
2021
Latest Award
2021
Program Status
Active
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

16 Brunswick Street
Quincy, MA 02171
   (617) 637-5821
   N/A
   www.altigg.com
Location: Single
Congr. District: 08
County: Norfolk

Public Profile

In collaboration with certain personnel affiliated with Mass General Hospital, Altigg Therapuetics Inc an early-stage, very young biotechnology company iaddressing development of human antibodies as therapeutics for infectious disease with a particular focus on Covid-10

Extent of SBIR involvement

User Avatar
Phase I Awards
1
Phase II Awards
0
Conversion Rate
0.00%
Phase I Dollars
$255,595
Phase II Dollars
$0
Total Awarded
$255,595

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2021 1 NSF $255,595
Project Title: A platform for the rapid discovery of human antibodies as therapeutics for infectious disease (COVID-19)

Key People / Management

  Bradley Poulsen -- Chief Scientific Officer

Company News

There are no news available.